G

Gossamer Bio

192 employees

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immunology
Health Care
Therapeutics
Fibrosis
Oncology
Inflammation
Inflammatory Bowel Disease

Date founded

2017

Funding rounds raised

Total raised

$230M

from 14 investors over 14 rounds

G

Gossamer Bio raised $120M on July 13, 2022

Investors: Monashee Investment Management LLC, The Invus Group and Weiss Asset Management

G

Gossamer Bio raised $150M on May 2, 2019

Investors: MidCap Financial

G

Gossamer Bio raised $230M on July 23, 2018

Investors: Hillhouse Capital Management, Abu Dhabi Investment Authority (ADIA), ARCH Venture Partners, Polaris Partners, The Invus Group, Omega Funds, Bay City Capital and The Baupost Group

G

Gossamer Bio raised $100M on January 4, 2018

Investors: ARCH Venture Partners and Omega Funds

FAQ